-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師的觀點摘要如下：我們將CRS的12個月目標價調高7美元至508美元，基於2028財年（截至6月）的EBITDA預期，其EV/EBITDA為18.5倍，與CRS過去12個月的平均預期EV/EBITDA 18.6倍基本一致。我們調高了每股盈餘預期：2026財年調高0.07美元至10.64美元，2027財年調高0.62美元至13.84美元，2028財年調高0.08美元至16.60美元。隨著航太週期加速，結構性需求出現轉折點，在鎳基高溫合金供應趨緊的情況下，引擎訂單激增，CRS仍處於非常有利的地位。我們預計，隨著SAO業務部門獲利能力長期目標達到40%以上，公司將維持持續的定價能力並進一步提升利潤率。 4億美元的現有產能擴建計畫僅能略微增加產能，與產業產能缺口相比，將維持2028財年及以後的良好供需關係。然而，儘管基本面強勁，但目前股價遠高於歷史EV/EBITDA倍數，因此我們下調了評級。鑑於CRS股價在過去一年上漲了112%，我們認為其股價已反映了大部分利好因素，上漲空間有限。
Related Articles
US Markets
AI Chipmaker Cerebras Targets Raising Up To $4 billion in IPO
Cerebras Systems plans to kick off the roadshow for its proposed initial public offering as the artificial intelligence chipmaker targets raising up to a little over $4 billion.The company is looking to offer 28 million class A common shares at between $115 and $125 per share, according to a preliminary prospectus filed with the Securities and Exchange Commission on Monday. The underwriters will have a 30-day option to purchase up to an additional 4.2 million class A shares.The aggregate share count yields about $4.03 billion, based on the top end of the expected price range' calculations showed.Cerebras has applied to list its class A shares on the Nasdaq Global Select Market under the symbol "CBRS," according to the filing.The company in October 2025 dropped its plans to go public, shortly after it raised $1.1 billion in a funding round at $8.1 billion post-money valuation.Cerebras, which competes with companies including Nvidia (NVDA) and Advanced Micro Devices (AMD) in the hardware category, reported 2025 net income of $1.38 per share on revenue of $510 million. That compares with a loss of $9.90 per share and revenue of $290.3 million in 2024.It also competes with cloud service providers such as Amazon (AMZN) Web Services and Microsoft's (MSFT) Azure, according to the filing.In April, the company said it had raised $2.85 billion in capital over a period of eight months, including a new credit facility for up to $850 million.Price: $196.70, Change: $-1.76, Percent Change: -0.88%
$AMD$AMZN$MSFT$NVDA
Research
Research Alert: CFRA Keeps Hold Opinion On Shares Of Everest Group, Ltd.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target by $15 to $365, valuing EG shares at 7x our 2026 operating EPS estimate of $53.16 (cut today by $0.99) and at 6x our 2027 EPs estimate of $60.65, versus the one-year average forward multiple of 6x and a peer average of 8.6x. We acknowledge EG's discounted valuation to peers, reflecting its restructuring. To that end, we expect revenues in 2026 to be flat to down 5%. Q1 operating EPS of $16.08 versus $6.45 a year ago topped our $15.27 estimate and the $13.96 consensus view. Operating revenues declined 4.4% on a 7.2% drop in earned premiums and 15% rise in investment income, while the combined ratio improved dramatically to 91.2% from 102.7%. We applaud EG's restructuring, including the sale of renewal rights to its retail commercial insurance business to focus on its core reinsurance operations. EG expects pre-tax charges of $250M-$350M over 2025-2026. We are concerned becoming a pure-play reinsurer may not expand valuation multiples given EG's mixed underwriting track record.
$EG
Research
Research Alert: CFRA Maintains Buy Opinion On Shares Of Xylem Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Following Q1 results, we trim our 12-month target to $140 from $160, applying a multiple more in line with the broader industrial machinery sub-industry. We value shares at 23.2x our 2027 EPS outlook of $6.02 (in line with previous forecast; 2026 EPS view revised to $5.52 from $5.50). XYL's organic revenues and orders were flat Y/Y, while adjusted EBITDA margins expanded by 20 bps and adjusted EPS increased by 9%. Measurement & Control saw a 15% increase in orders driven by smart metering demand, while Applied Water experienced a surge in orders related to data centers. These gains were offset by declines in the Water Infrastructure and Water Solutions & Services, which was impacted by strategic "walkaway" actions, softness in China, and timing of capital projects. We reiterate our Buy opinion on shares, though we do acknowledge heightened risk associated with a more back-half-weighted earnings guide, with Q3 and Q4 having higher expectations.
$XYL